Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
Mark Brantly(University of Florida), Terence R. Flotte(University of Massachusetts Chan Medical School), Michael R. Betts(University of Pennsylvania), Roberto Calcedo(Johns Hopkins University), James M. Wilson(St Bartholomew's Hospital), L. Terry Spencer(University of Florida), Margaret Humphries(University of Massachusetts Chan Medical School), Barry J. Byrne(University of Florida), Jeffrey D. Chulay(Research Triangle Park Foundation), Farshid N. Rouhani(University of Florida), Lili Wang(Hunan Agricultural University), Christian Mueller(AbbVie (Germany)), Carolyn Spencer(Boston Children's Hospital), Thomas J. Conlon(Adelson Foundation)
Cited by 322
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
HIV preferentially infects HIV-specific CD4+ T cells
|Nature|2002|1.3k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k